Analytical Data
-
基因名
C1qtnf6
- Application
-
别名
C1qtnf6；CTRP6；Complement C1q tumor necrosis factor-related Protein 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6IR41
-
表达区间
25-264aa
-
氨基酸序列
VPTEETTFGESVASHLPKGCRRCCDPEDLMSSDDTVQAPVSPYVLPEVRPYINITILKGDKGDRGPTGTPGKPGKNGTRGDRGSQGVKGDKGQAGSPGSSCQTHYSAFSVGRKTGLHSSENFLSLLFDRVFVNTDGHFDMATGSFVAPLRGLYFFSLNVHSWNYKETYVHIVHNEQAVVILYAQPSERSIMQSQSVMLPLVPGDRVWVRLFKRERENGIYSDDVDTYITFSGHLIKAEDN
-
分子量
39.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1qtnf6, a member of the complement component C1q family, has gained interest in recent years due to its potential roles in various biological processes, including immunomodulation, cell signaling, and the regulation of adipocyte function. Originally identified for its involvement in the complement system, emerging studies suggest that C1qtnf6 might play significant roles in metabolism and inflammation, linking it to conditions such as obesity and metabolic syndrome. Its expression is notably influenced by factors such as adipocyte differentiation and inflammatory cytokines, indicating a complex regulatory mechanism. Researchers are exploring C1qtnf6’s influence on insulin sensitivity, lipid metabolism, and the inflammatory response, which may pave the way for novel therapeutic targets for metabolic disorders. Understanding the functional implications of C1qtnf6 at the molecular level could provide insights into the interplay between immune responses and metabolic health, highlighting its potential as a biomarker or therapeutic target in diseases characterized by chronic inflammation, such as type 2 diabetes and cardiovascular diseases. As the scientific community continues to investigate the diverse functions of C1qtnf6, its reconstitution and functional studies using recombinant protein may elucidate its contributions to cellular physiology and pathophysiology.
